Christy Shaffer

Christy L.
Shaffer currently works at EvoApp, Inc., as Director, The Biotechnology Institute, as Director, Council for Entrepreneurial Development, as Director, PhRMA Foundation, as Director, Clearside Biomedical, Inc., as Independent Director from 2018, Artizan Biosciences, Inc., as Director, Trefoil Therapeutics, Inc., as Director, Chordoma Foundation, as Director from 2016, Perfuse Therapeutics, Inc., as Director, Hatteras Discovery, as Managing Director from 2011, Aer Therapeutics, Inc., as Director, Research Triangle Institute, as Member-Governors Board, and Hatteras Venture Partners, as General Partner from 2016.
Dr. Shaffer also formerly worked at Inspire Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2005 to 2009, Cystic Fibrosis Foundation Therapeutics, Inc., as Chairman, G1 Therapeutics, Inc., as Executive Chairman from 2014 to 2018, Trefoil Therapeutics, Inc., as Chairman, KinoDyn, Inc., as Chairman, Clinipace, Inc., as Director from 2008 to 2011, Graybug Vision, Inc., as Director in 2015, Spyryx Biosciences, Inc., as Director, Burroughs Wellcome, as Associate Director-Pulmonary & Critical Care, North Carolina School of Science & Mathematics Foundation, as Director, Pulmonary Critical Care Management, Inc., as Associate Director, Cystic Fibrosis Foundation, as Trustee from 2011 to 2014, and The North Carolina Biotechnology Center, as Principal.
Dr. Shaffer received her doctorate degree in 1985 from The University of Tennessee Health Science Center.